MSB 4.59% $1.14 mesoblast limited

Japan as a Funding Source, page-13

  1. 384 Posts.
    lightbulb Created with Sketch. 5
    Vinny ..here is a reference to the recent Japan delegation.

    http://www.copyright link/business/...ng-with-australian-technology-20170425-gvrpo9

    ..."Having missed the earlier antibody revolution (mainly around cancer drugs), Japan is betting big that regenerative medicine is the way of the future "...

    As aGVHD is currently available via JCR, in my view Japan will be looking to the next most advanced MSB application.
    So I'll be keeping an eye out to see what happens with Revascor - particularly in view of the recent green light by the IDMC.

    GLTAH.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.14
Change
0.050(4.59%)
Mkt cap ! $1.301B
Open High Low Value Volume
$1.10 $1.14 $1.08 $6.654M 5.972M

Buyers (Bids)

No. Vol. Price($)
2 1330 $1.14
 

Sellers (Offers)

Price($) Vol. No.
$1.14 171164 10
View Market Depth
Last trade - 16.10pm 18/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.